1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Nitric Oxide Therapy Systems Market
2.2. Global Nitric Oxide Therapy Systems Market, By Type, 2023 (US$ Million)
2.3. Global Nitric Oxide Therapy Systems Market, By End Users, 2023 (US$ Million)
2.4. Global Nitric Oxide Therapy Systems Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Nitric Oxide Therapy Systems Market: Competitive Analysis
3.1. Market Positioning of Key Nitric Oxide Therapy Systems Market Vendors
3.2. Strategies Adopted by Nitric Oxide Therapy Systems Market Vendors
3.3. Key Industry Strategies
4. Nitric Oxide Therapy Systems Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Nitric Oxide Therapy Systems Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Portable Nitric Oxide Therapy Systems
5.3.2. Fixed Nitric Oxide Therapy Systems

6. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Hospitals
6.3.2. Homecare Settings
6.3.3. Clinics


7. North America Nitric Oxide Therapy Systems Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
7.3. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
7.4.Nitric Oxide Therapy Systems Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
7.4.1.1.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
7.4.1.2.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
7.4.1.3.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)

8. UK and European Union Nitric Oxide Therapy Systems Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
8.3. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
8.4.Nitric Oxide Therapy Systems Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
8.4.1.1.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
8.4.1.2.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
8.4.1.3.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
8.4.1.4.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
8.4.1.5.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
8.4.1.6.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)

9. Asia Pacific Nitric Oxide Therapy Systems Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
9.3. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
9.4.Nitric Oxide Therapy Systems Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
9.4.1.1.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
9.4.1.2.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
9.4.1.3.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
9.4.1.4.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
9.4.1.5.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
9.4.1.6.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)

10. Latin America Nitric Oxide Therapy Systems Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
10.3. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
10.4.Nitric Oxide Therapy Systems Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
10.4.1.1.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
10.4.1.2.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
10.4.1.3.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)

11. Middle East and Africa Nitric Oxide Therapy Systems Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
11.3. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
11.4.Nitric Oxide Therapy Systems Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
11.4.1.1.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
11.4.1.2.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Nitric Oxide Therapy Systems Market: By Type, 2022-2032, USD (Million)
11.4.1.3.2. Nitric Oxide Therapy Systems Market: By End Users, 2022-2032, USD (Million)

12. Company Profile
12.1. Bellerophon Therapeutics
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. BOC Healthcare
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Dan Hammer Health Ltd.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. EKU Elektronik GmbH
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. GeNO, LLC
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. International Biomedical
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. SLE
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Mallinckrodt Pharmaceuticals
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Praxair, Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Vapotherm
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives